1. Home
  2. HWKN vs TMDX Comparison

HWKN vs TMDX Comparison

Compare HWKN & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HWKN
  • TMDX
  • Stock Information
  • Founded
  • HWKN 1938
  • TMDX 1998
  • Country
  • HWKN United States
  • TMDX United States
  • Employees
  • HWKN N/A
  • TMDX N/A
  • Industry
  • HWKN Specialty Chemicals
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • HWKN Consumer Discretionary
  • TMDX Health Care
  • Exchange
  • HWKN Nasdaq
  • TMDX Nasdaq
  • Market Cap
  • HWKN 2.5B
  • TMDX 2.3B
  • IPO Year
  • HWKN N/A
  • TMDX 2019
  • Fundamental
  • Price
  • HWKN $119.39
  • TMDX $93.20
  • Analyst Decision
  • HWKN Strong Buy
  • TMDX Buy
  • Analyst Count
  • HWKN 1
  • TMDX 10
  • Target Price
  • HWKN $160.00
  • TMDX $120.11
  • AVG Volume (30 Days)
  • HWKN 108.9K
  • TMDX 1.1M
  • Earning Date
  • HWKN 05-14-2025
  • TMDX 05-08-2025
  • Dividend Yield
  • HWKN 0.60%
  • TMDX N/A
  • EPS Growth
  • HWKN 12.32
  • TMDX N/A
  • EPS
  • HWKN 3.91
  • TMDX 1.01
  • Revenue
  • HWKN $952,133,000.00
  • TMDX $441,540,000.00
  • Revenue This Year
  • HWKN $6.51
  • TMDX $25.33
  • Revenue Next Year
  • HWKN $7.56
  • TMDX $20.53
  • P/E Ratio
  • HWKN $30.54
  • TMDX $92.28
  • Revenue Growth
  • HWKN 3.01
  • TMDX 82.74
  • 52 Week Low
  • HWKN $71.98
  • TMDX $55.00
  • 52 Week High
  • HWKN $139.55
  • TMDX $177.37
  • Technical
  • Relative Strength Index (RSI)
  • HWKN 52.74
  • TMDX 63.43
  • Support Level
  • HWKN $116.84
  • TMDX $89.10
  • Resistance Level
  • HWKN $124.44
  • TMDX $95.71
  • Average True Range (ATR)
  • HWKN 4.05
  • TMDX 4.15
  • MACD
  • HWKN -0.84
  • TMDX -0.23
  • Stochastic Oscillator
  • HWKN 25.10
  • TMDX 57.13

About HWKN Hawkins Inc.

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: